Company Filing History:

4 out of 1,454

Sanofi

Behringwerke Aktiengesellschaft

where one patent can have more than one assignee

Years Active: 1992-2000

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6017762 - Cassette for the expression of an endothiapepsin precursor in (2000-01-25),

2. 5902735 - Functional DNA block and plasmid coding for hirudin, transformed yeast, (1999-05-11),

3. 5821079 - Vectors for the expression and secretion of hirudin by transformed yeasts (1998-10-13),

4. 5650301 - Hirudin HV2 having a SN7LYS substitution, method of making, and method (1997-07-22),

5. 5597570 - Protein recognized by antibodies raised against native P28 of (1997-01-28),

6. 5591640 - Functional DNA block and plasmid coding for hirudin, transformed yeast, (1997-01-07),

7. 5407822 - Artificial promoter for the expression of proteins in yeast (1995-04-18),

8. 5382518 - Urate oxidase activity protein, recombinant gene coding therefor, (1995-01-17),

9. 5284768 - Signal peptide, DNA sequences coding for the latter, expression vectors (1994-02-08),

10. 5087613 - Hirudin variants (1992-02-11),

Title: The Innovations of Gerard Loison

Introduction

Gerard Loison is a prominent inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for protein expression. With a total of 10 patents, his work has had a considerable impact on the industry.

Latest Patents

Among his latest patents is a cassette for the expression of an endothiapepsin precursor in Cryphonectria parasitica. This invention relates to a new method for preparing endothiapepsin using a transformed strain of this species, as well as a process for creating such a strain devoid of a dominant selection marker. Another notable patent involves a functional DNA block and plasmid coding for hirudin, which allows for the preparation of hirudin from yeast.

Career Highlights

Throughout his career, Gerard Loison has worked with notable companies such as Sanofi and Transgene S.A. His expertise in biotechnology has enabled him to develop innovative solutions that address complex challenges in the field.

Collaborations

Gerard has collaborated with esteemed colleagues, including Yves Lemoine and Richard Legoux. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in biotechnology.

Conclusion

Gerard Loison's contributions to the field of biotechnology through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com